Jim McGuire, PhD
Jim McGuire is a veteran of the biotech and pharma industry where he has led multiple drug discovery groups and projects. He earned his PhD in Organic Chemistry from the University of Illinois at Urbana-Champaign and followed with a postdoc at the University of Copenhagen. He went on to work with small molecule ADME at H. Lundbeck A/S and protein biomarkers at Ciphergen, Inc. followed by 15 years at Novo Nordisk A/S, where he focused on biologics in the cardiometabolic space with an increasing level of people and project responsibility. He helped lead 13 projects from discovery to development including a number of GLP-1 therapies. In addition he was part of bringing semaglutide to the market as the once-weekly injectable Ozempic. He was most recently an Executive Director of Translational Research at Catalyst Biosciences where he led their discovery efforts and helped bring two complement programs into development. He has co-authored 23 peer-reviewed articles and four patents.
Learn more about Jim